491 Edward H. Ross Drive in Elmwood Park — Courtesy: Alfred Sanzari Enterprises
By Joshua Burd
One of the nation’s largest specialty laboratories has renewed its three-building, 160,000-square-foot lease across three Elmwood Park properties owned by Alfred Sanzari Enterprises.
BioReference Laboratories, an OPKO Health company, is a longtime tenant of the commercial real estate firm, with a footprint that stretches across 481, 487 and 491 Edward H. Ross Drive. It’s also among the most prestigious, servicing roughly 19 million patients annually and playing a critical role in the nation’s response to the COVID-19 pandemic.
It will continue to occupy the three industrial buildings — located near the nexus of Interstate 80 and the Garden State Parkway — under the latest long-term renewal with Sanzari. Chris Olsen of Eagle Real Estate Group represented BioReference in the transaction, with Jan Lewis of Cole Schotz PC providing legal counsel to the landlord.
“Having worked closely together for over 20 years, our relationship with BioReference has become a trusted partnership and we are proud that they will continue to call our Elmwood Park properties home,” said Stephen Jennings, vice president of leasing and marketing at Alfred Sanzari Enterprises. “Their multi-decade presence at our Elmwood Park industrial properties is a testament to Alfred Sanzari Enterprises’ reputation for strong tenant retention and how our long-term ownership strategy ensures our tenants can secure the space they need to support their long-term needs.”
In a news release, ASE noted that BioReference has a leading position in genetics, women’s health, oncology and urology. The company operates a network of 10 lab locations and serves as an industry leader in custom solutions for COVID-19 testing, including point-of-care testing and large-scale screening programs, which have been crucial in the nation’s pandemic response.